FDA greenlights 5-minute tests to track Humira, Remicade doses in patients with inflammatory bowel disease
The FDA has granted a pair of de novo clearances to ProciseDx for the agency’s first rapid tests to measure the levels of specific biologic drugs within a patient’s bloodstream—allowing clinicians | The FDA has granted a pair of de novo clearances to ProciseDx for the agency’s first rapid tests...